GLP-1 · Mechanism
How do GLP-1 medications work? Mechanism, effects, and what to expect
GLP-1 receptor agonists are the most transformative metabolic drugs in 40 years. Understanding the mechanism — not the marketing — helps you predict what will happen in your body, week by week.
The four mechanisms
- Appetite suppression. Hypothalamic POMC neurons fire; "food noise" quiets.
- Slowed gastric emptying. You feel full sooner and stay full longer.
- Insulin sensitivity. Pancreatic beta cells respond better; glucagon falls.
- Visceral fat reduction. Preferential loss of the metabolically dangerous fat around organs.
What you actually feel, week by week
- Week 1-2: Reduced hunger, mild nausea, smaller meal sizes.
- Week 4-8: Weight loss accelerates, food preferences shift toward less-processed choices.
- Month 3-6: Steady weight loss, waist reduction, improved lipids and A1c.
- Month 6-12: Plateau approaches; body-composition work matters most.
Related reading
Semaglutide guide · Tirzepatide vs semaglutide · Microdosing GLP-1 · Managing side effects.
Frequently asked questions
What does GLP-1 do in the body?
GLP-1 is a gut hormone released after meals. It stimulates insulin, suppresses glucagon, slows gastric emptying, and activates hypothalamic appetite neurons. Drugs like semaglutide and tirzepatide bind the GLP-1 receptor for days at a time.
How fast does a GLP-1 start working?
Appetite drops within days. Weight loss typically appears in week 2-4 and accelerates through months 3-9. Insulin sensitivity improves within weeks.
Why do GLP-1s cause nausea?
Slowed gastric emptying and central nervous system effects on the area postrema (the brain's nausea center). Almost always resolves within 2 weeks of a stable dose.
Do GLP-1s work if you don't change your diet?
Somewhat, but poorly. GLP-1s reduce hunger; they do not compose meals. Protein and resistance training are what preserve muscle and maintain weight loss.
Are all GLP-1s the same?
No. Semaglutide is GLP-1 only. Tirzepatide is GLP-1 + GIP. Retatrutide (investigational) adds glucagon. Each additional receptor changes effect size and side-effect profile.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.